Header image
Click on the session title to view the presentations and speakers included in each session as well as abstracts and speaker biographies.

Thursday, September 2, 2021

Track 1
1:00 AM - 2:00 AM On Demand Topic: Addressing Drug Related Harms
On Demand Topic: Enhancing The Care Cascade
On Demand Topic: HCV And HIV Epidemiology
On Demand Topic: HCV And HIV Models Of Care
On Demand Topic: HCV Reinfection
On Demand Topic: HCV Treatment Options
On Demand Topic: Impact Of COVID-19 On People Who Use Drugs
On Demand Topic: Other Infectious Diseases
Track 1
1:00 AM - 2:00 AM On Demand Topic: Addressing Drug Related Harms
On Demand Topic: Enhancing The Care Cascade
On Demand Topic: HCV And HIV Epidemiology
On Demand Topic: HCV And HIV Models Of Care
On Demand Topic: HCV Reinfection
On Demand Topic: HCV Treatment Options
On Demand Topic: Impact Of COVID-19 On People Who Use Drugs
On Demand Topic: Other Infectious Diseases

Track 1
1:00 AM - 2:00 AM On Demand Topic: Addressing Drug Related Harms
On Demand Topic: Enhancing The Care Cascade
On Demand Topic: HCV And HIV Epidemiology
On Demand Topic: HCV And HIV Models Of Care
On Demand Topic: HCV Reinfection
On Demand Topic: HCV Treatment Options
On Demand Topic: Impact Of COVID-19 On People Who Use Drugs
On Demand Topic: Other Infectious Diseases

Friday, October 1, 2021

Track 1
9:30 PM - 10:00 PM
REHEARSAL: The Health of People Who Use Drugs and Universal Health Coverage
Track 1
9:30 PM - 10:00 PM
REHEARSAL: The Health of People Who Use Drugs and Universal Health Coverage

Track 1
9:30 PM - 10:00 PM
REHEARSAL: The Health of People Who Use Drugs and Universal Health Coverage

Tuesday, October 5, 2021

Track 1
3:00 PM - 3:30 PM
Speaker Briefing 1
3:45 PM - 4:15 PM
Speaker Briefing 2
4:30 PM - 5:00 PM
Speaker Briefing 3
5:15 PM - 5:45 PM
Speaker Briefing 4
6:00 PM - 6:30 PM
Speaker Briefing 5
6:45 PM - 7:15 PM
Speaker Briefing 6
7:55 PM - 8:00 PM
Speaker Briefing 7
8:00 PM - 9:00 PM The health of people who use drugs and Universal Health Coverage: what are we actually talking about?
Track 1
3:00 PM - 3:30 PM
Speaker Briefing 1
3:45 PM - 4:15 PM
Speaker Briefing 2
4:30 PM - 5:00 PM
Speaker Briefing 3
5:15 PM - 5:45 PM
Speaker Briefing 4
6:00 PM - 6:30 PM
Speaker Briefing 5
6:45 PM - 7:15 PM
Speaker Briefing 6
7:55 PM - 8:00 PM
Speaker Briefing 7
8:00 PM - 9:00 PM The health of people who use drugs and Universal Health Coverage: what are we actually talking about?

Track 1
3:00 PM - 3:30 PM
Speaker Briefing 1
3:45 PM - 4:15 PM
Speaker Briefing 2
4:30 PM - 5:00 PM
Speaker Briefing 3
5:15 PM - 5:45 PM
Speaker Briefing 4
6:00 PM - 6:30 PM
Speaker Briefing 5
6:45 PM - 7:15 PM
Speaker Briefing 6
7:55 PM - 8:00 PM
Speaker Briefing 7
8:00 PM - 9:00 PM The health of people who use drugs and Universal Health Coverage: what are we actually talking about?

Wednesday, October 6, 2021

Track 1
7:30 AM - 8:00 AM
Speaker Briefing 8
8:15 AM - 8:45 AM
Speaker Briefing 9
9:00 AM - 9:30 AM
Speaker Briefing 10
9:30 AM - 10:15 AM
Nurses Satellite Session Rehearsal
9:45 AM - 10:15 AM
Speaker Briefing 11
10:30 AM - 11:00 AM
Speaker Briefing 12
3:30 PM - 4:00 PM
Speaker Briefing 13
4:15 PM - 4:45 PM
Speaker Briefing 14
5:00 PM - 5:30 PM
Speaker Briefing 15
5:45 PM - 6:15 PM
Speaker Briefing 16
6:30 PM - 7:00 PM
Speaker Briefing 17
7:15 PM - 7:45 PM
EMCR Communications Session Rehearsal
Track 1
7:30 AM - 8:00 AM
Speaker Briefing 8
8:15 AM - 8:45 AM
Speaker Briefing 9
9:00 AM - 9:30 AM
Speaker Briefing 10
9:30 AM - 10:15 AM
Nurses Satellite Session Rehearsal
9:45 AM - 10:15 AM
Speaker Briefing 11
10:30 AM - 11:00 AM
Speaker Briefing 12
3:30 PM - 4:00 PM
Speaker Briefing 13
4:15 PM - 4:45 PM
Speaker Briefing 14
5:00 PM - 5:30 PM
Speaker Briefing 15
5:45 PM - 6:15 PM
Speaker Briefing 16
6:30 PM - 7:00 PM
Speaker Briefing 17
7:15 PM - 7:45 PM
EMCR Communications Session Rehearsal

Track 1
7:30 AM - 8:00 AM
Speaker Briefing 8
8:15 AM - 8:45 AM
Speaker Briefing 9
9:00 AM - 9:30 AM
Speaker Briefing 10
9:30 AM - 10:15 AM
Nurses Satellite Session Rehearsal
9:45 AM - 10:15 AM
Speaker Briefing 11
10:30 AM - 11:00 AM
Speaker Briefing 12
3:30 PM - 4:00 PM
Speaker Briefing 13
4:15 PM - 4:45 PM
Speaker Briefing 14
5:00 PM - 5:30 PM
Speaker Briefing 15
5:45 PM - 6:15 PM
Speaker Briefing 16
6:30 PM - 7:00 PM
Speaker Briefing 17
7:15 PM - 7:45 PM
EMCR Communications Session Rehearsal

Thursday, October 7, 2021

Track 1
7:15 AM - 7:45 AM
Speaker Briefing 18
8:00 AM - 8:30 AM
Speaker Briefing 19
8:45 AM - 9:15 AM
Speaker Briefing 20
9:30 AM - 10:00 AM
Speaker Briefing 21
4:00 PM - 4:30 PM
Speaker Briefing 22
4:45 PM - 5:15 PM
Speaker Briefing 23
5:30 PM - 6:00 PM
Speaker Briefing 24
6:15 PM - 6:45 PM
Speaker Briefing 25
Track 1
7:15 AM - 7:45 AM
Speaker Briefing 18
8:00 AM - 8:30 AM
Speaker Briefing 19
8:45 AM - 9:15 AM
Speaker Briefing 20
9:30 AM - 10:00 AM
Speaker Briefing 21
4:00 PM - 4:30 PM
Speaker Briefing 22
4:45 PM - 5:15 PM
Speaker Briefing 23
5:30 PM - 6:00 PM
Speaker Briefing 24
6:15 PM - 6:45 PM
Speaker Briefing 25

Track 1
7:15 AM - 7:45 AM
Speaker Briefing 18
8:00 AM - 8:30 AM
Speaker Briefing 19
8:45 AM - 9:15 AM
Speaker Briefing 20
9:30 AM - 10:00 AM
Speaker Briefing 21
4:00 PM - 4:30 PM
Speaker Briefing 22
4:45 PM - 5:15 PM
Speaker Briefing 23
5:30 PM - 6:00 PM
Speaker Briefing 24
6:15 PM - 6:45 PM
Speaker Briefing 25

Friday, October 8, 2021

Track 1
7:30 AM - 8:00 AM
Speaker Briefing 26
8:15 AM - 8:45 AM
Speaker Briefing 27
12:00 PM - 12:50 PM
Speaker Briefing 28
5:00 PM - 5:30 PM
Speaker Briefing 29
Track 1
7:30 AM - 8:00 AM
Speaker Briefing 26
8:15 AM - 8:45 AM
Speaker Briefing 27
12:00 PM - 12:50 PM
Speaker Briefing 28
5:00 PM - 5:30 PM
Speaker Briefing 29

Track 1
7:30 AM - 8:00 AM
Speaker Briefing 26
8:15 AM - 8:45 AM
Speaker Briefing 27
12:00 PM - 12:50 PM
Speaker Briefing 28
5:00 PM - 5:30 PM
Speaker Briefing 29

Monday, October 11, 2021

Track 1
6:00 PM - 6:30 PM
REHEARSAL: Hepatitis C Self-Testing: Empowering People who use Drugs and Increasing Access to HCV Testing and Care
6:00 PM - 7:00 PM
Cepheid Demo Session
Track 1
6:00 PM - 6:30 PM
REHEARSAL: Hepatitis C Self-Testing: Empowering People who use Drugs and Increasing Access to HCV Testing and Care
6:00 PM - 7:00 PM
Cepheid Demo Session

Track 1
6:00 PM - 6:30 PM
REHEARSAL: Hepatitis C Self-Testing: Empowering People who use Drugs and Increasing Access to HCV Testing and Care
6:00 PM - 7:00 PM
Cepheid Demo Session

Tuesday, October 12, 2021

Track 1
8:00 AM - 8:30 AM
EMCR Satellite Session Rehearsal
Track 1
8:00 AM - 8:30 AM
EMCR Satellite Session Rehearsal

Track 1
8:00 AM - 8:30 AM
EMCR Satellite Session Rehearsal

Wednesday, October 13, 2021

Track 1
Track 2
Track 3
8:00 AM - 8:29 AM
Portal Demonstration Video - Day 1
8:30 AM - 10:30 AM Opening Ceremony & Plenary Session
10:30 AM - 11:10 AM
Coffee Break & Exhibition Open - Wednesday Morning
Concurrent Session 1
11:10 AM - 12:45 PM 		Innovations to Enhance the Health of People Who Use Drugs Policy and Advocacy Next Steps to Improve the Health of People Who Use Drugs
Don’t you know there’s a pandemic on? How nurses are striving for HCV elimination in the time of COVID
12:45 PM - 2:25 PM
Lunch & Exhibition Open - Wednesday
1:15 PM - 2:15 PM Industry Sponsored Symposium - Putting the individual first: patient-centric management of HCV
After watching the recording, Gilead would appreciate your feedback: www.surveymonkey.com/r/puttingtheindividualfirst Join Jason Grebely, Chris Gough, Joss O’Loan and Leanne Myers for the Gilead-sponsored symposium ‘Putting the individual first: patient-centric management of HCV’, taking place from 13.15–14.15 AEDT on Wednesday 13 October 2021, during the 9th International Conference on Hepatitis Care in Substances Users. Great strides have been made to simplify the HCV care cascade, allowing more patients to access HCV care and curative treatment. However, linking vulnerable people with HCV infection to care, such as those who use drugs, remains an area that can be improved. To engage these patients, we have to do more to address their concerns. In this symposium, the panel will discuss how even with a legacy of stigma and discrimination, patients can become empowered to seek the care they deserve. The expert faculty will share examples of how treatment individualisation and integration of HCV care with multiple stakeholders has helped to overcome these barriers and is improving rates of treatment uptake in these patients.
Concurrent Session 2
2:25 PM - 3:55 PM 		Research Oral Abstract Session - Addressing Drug Related Harms Hepatitis C Models of Care Abstracts
3:55 PM - 4:25 PM
Coffee Break & Exhibition Open - Wednesday Afternoon
Concurrent Session 3
4:25 PM - 5:20 PM 		Research Oral Abstract Session - Hospitalisations among people who use drugs Research Oral Abstract Session - Changes in Drug Use
5:20 PM - 5:50 PM
Virtual Networking - Day 1
Track 1
Track 2
8:00 AM - 8:29 AM
Portal Demonstration Video - Day 1
8:30 AM - 10:30 AM Opening Ceremony & Plenary Session
10:30 AM - 11:10 AM
Coffee Break & Exhibition Open - Wednesday Morning
Concurrent Session 1
11:10 AM - 12:45 PM 		Innovations to Enhance the Health of People Who Use Drugs Policy and Advocacy Next Steps to Improve the Health of People Who Use Drugs
12:45 PM - 2:25 PM
Lunch & Exhibition Open - Wednesday
1:15 PM - 2:15 PM Industry Sponsored Symposium - Putting the individual first: patient-centric management of HCV
After watching the recording, Gilead would appreciate your feedback: www.surveymonkey.com/r/puttingtheindividualfirst Join Jason Grebely, Chris Gough, Joss O’Loan and Leanne Myers for the Gilead-sponsored symposium ‘Putting the individual first: patient-centric management of HCV’, taking place from 13.15–14.15 AEDT on Wednesday 13 October 2021, during the 9th International Conference on Hepatitis Care in Substances Users. Great strides have been made to simplify the HCV care cascade, allowing more patients to access HCV care and curative treatment. However, linking vulnerable people with HCV infection to care, such as those who use drugs, remains an area that can be improved. To engage these patients, we have to do more to address their concerns. In this symposium, the panel will discuss how even with a legacy of stigma and discrimination, patients can become empowered to seek the care they deserve. The expert faculty will share examples of how treatment individualisation and integration of HCV care with multiple stakeholders has helped to overcome these barriers and is improving rates of treatment uptake in these patients.
Concurrent Session 2
2:25 PM - 3:55 PM 		Research Oral Abstract Session - Addressing Drug Related Harms Hepatitis C Models of Care Abstracts
3:55 PM - 4:25 PM
Coffee Break & Exhibition Open - Wednesday Afternoon
Concurrent Session 3
4:25 PM - 5:20 PM 		Research Oral Abstract Session - Hospitalisations among people who use drugs Research Oral Abstract Session - Changes in Drug Use
5:20 PM - 5:50 PM
Virtual Networking - Day 1

Track 3
8:00 AM - 8:29 AM
Portal Demonstration Video - Day 1
8:30 AM - 10:30 AM Opening Ceremony & Plenary Session
10:30 AM - 11:10 AM
Coffee Break & Exhibition Open - Wednesday Morning
Concurrent Session 1
11:10 AM - 12:45 PM
Don’t you know there’s a pandemic on? How nurses are striving for HCV elimination in the time of COVID
12:45 PM - 2:25 PM
Lunch & Exhibition Open - Wednesday
1:15 PM - 2:15 PM Industry Sponsored Symposium - Putting the individual first: patient-centric management of HCV
After watching the recording, Gilead would appreciate your feedback: www.surveymonkey.com/r/puttingtheindividualfirst Join Jason Grebely, Chris Gough, Joss O’Loan and Leanne Myers for the Gilead-sponsored symposium ‘Putting the individual first: patient-centric management of HCV’, taking place from 13.15–14.15 AEDT on Wednesday 13 October 2021, during the 9th International Conference on Hepatitis Care in Substances Users. Great strides have been made to simplify the HCV care cascade, allowing more patients to access HCV care and curative treatment. However, linking vulnerable people with HCV infection to care, such as those who use drugs, remains an area that can be improved. To engage these patients, we have to do more to address their concerns. In this symposium, the panel will discuss how even with a legacy of stigma and discrimination, patients can become empowered to seek the care they deserve. The expert faculty will share examples of how treatment individualisation and integration of HCV care with multiple stakeholders has helped to overcome these barriers and is improving rates of treatment uptake in these patients.
Concurrent Session 2
2:25 PM - 3:55 PM 		Hepatitis C Models of Care Abstracts
3:55 PM - 4:25 PM
Coffee Break & Exhibition Open - Wednesday Afternoon
Concurrent Session 3
4:25 PM - 5:20 PM 		Research Oral Abstract Session - Changes in Drug Use
5:20 PM - 5:50 PM
Virtual Networking - Day 1

Track 1
8:00 AM - 8:29 AM
Portal Demonstration Video - Day 1
8:30 AM - 10:30 AM Opening Ceremony & Plenary Session
10:30 AM - 11:10 AM
Coffee Break & Exhibition Open - Wednesday Morning
Concurrent Session 1
11:10 AM - 12:45 PM 		Innovations to Enhance the Health of People Who Use Drugs
12:45 PM - 2:25 PM
Lunch & Exhibition Open - Wednesday
1:15 PM - 2:15 PM Industry Sponsored Symposium - Putting the individual first: patient-centric management of HCV
After watching the recording, Gilead would appreciate your feedback: www.surveymonkey.com/r/puttingtheindividualfirst Join Jason Grebely, Chris Gough, Joss O’Loan and Leanne Myers for the Gilead-sponsored symposium ‘Putting the individual first: patient-centric management of HCV’, taking place from 13.15–14.15 AEDT on Wednesday 13 October 2021, during the 9th International Conference on Hepatitis Care in Substances Users. Great strides have been made to simplify the HCV care cascade, allowing more patients to access HCV care and curative treatment. However, linking vulnerable people with HCV infection to care, such as those who use drugs, remains an area that can be improved. To engage these patients, we have to do more to address their concerns. In this symposium, the panel will discuss how even with a legacy of stigma and discrimination, patients can become empowered to seek the care they deserve. The expert faculty will share examples of how treatment individualisation and integration of HCV care with multiple stakeholders has helped to overcome these barriers and is improving rates of treatment uptake in these patients.
Concurrent Session 2
2:25 PM - 3:55 PM 		Research Oral Abstract Session - Addressing Drug Related Harms
3:55 PM - 4:25 PM
Coffee Break & Exhibition Open - Wednesday Afternoon
Concurrent Session 3
4:25 PM - 5:20 PM 		Research Oral Abstract Session - Hospitalisations among people who use drugs
5:20 PM - 5:50 PM
Virtual Networking - Day 1

Track 2
8:00 AM - 8:29 AM
Portal Demonstration Video - Day 1
8:30 AM - 10:30 AM Opening Ceremony & Plenary Session
10:30 AM - 11:10 AM
Coffee Break & Exhibition Open - Wednesday Morning
Concurrent Session 1
11:10 AM - 12:45 PM 		Policy and Advocacy Next Steps to Improve the Health of People Who Use Drugs
12:45 PM - 2:25 PM
Lunch & Exhibition Open - Wednesday
1:15 PM - 2:15 PM Industry Sponsored Symposium - Putting the individual first: patient-centric management of HCV
After watching the recording, Gilead would appreciate your feedback: www.surveymonkey.com/r/puttingtheindividualfirst Join Jason Grebely, Chris Gough, Joss O’Loan and Leanne Myers for the Gilead-sponsored symposium ‘Putting the individual first: patient-centric management of HCV’, taking place from 13.15–14.15 AEDT on Wednesday 13 October 2021, during the 9th International Conference on Hepatitis Care in Substances Users. Great strides have been made to simplify the HCV care cascade, allowing more patients to access HCV care and curative treatment. However, linking vulnerable people with HCV infection to care, such as those who use drugs, remains an area that can be improved. To engage these patients, we have to do more to address their concerns. In this symposium, the panel will discuss how even with a legacy of stigma and discrimination, patients can become empowered to seek the care they deserve. The expert faculty will share examples of how treatment individualisation and integration of HCV care with multiple stakeholders has helped to overcome these barriers and is improving rates of treatment uptake in these patients.
Concurrent Session 2
2:25 PM - 3:55 PM 		Hepatitis C Models of Care Abstracts
3:55 PM - 4:25 PM
Coffee Break & Exhibition Open - Wednesday Afternoon
Concurrent Session 3
4:25 PM - 5:20 PM 		Research Oral Abstract Session - Changes in Drug Use
5:20 PM - 5:50 PM
Virtual Networking - Day 1

Track 3
8:00 AM - 8:29 AM
Portal Demonstration Video - Day 1
8:30 AM - 10:30 AM Opening Ceremony & Plenary Session
10:30 AM - 11:10 AM
Coffee Break & Exhibition Open - Wednesday Morning
Concurrent Session 1
11:10 AM - 12:45 PM
Don’t you know there’s a pandemic on? How nurses are striving for HCV elimination in the time of COVID
12:45 PM - 2:25 PM
Lunch & Exhibition Open - Wednesday
1:15 PM - 2:15 PM Industry Sponsored Symposium - Putting the individual first: patient-centric management of HCV
After watching the recording, Gilead would appreciate your feedback: www.surveymonkey.com/r/puttingtheindividualfirst Join Jason Grebely, Chris Gough, Joss O’Loan and Leanne Myers for the Gilead-sponsored symposium ‘Putting the individual first: patient-centric management of HCV’, taking place from 13.15–14.15 AEDT on Wednesday 13 October 2021, during the 9th International Conference on Hepatitis Care in Substances Users. Great strides have been made to simplify the HCV care cascade, allowing more patients to access HCV care and curative treatment. However, linking vulnerable people with HCV infection to care, such as those who use drugs, remains an area that can be improved. To engage these patients, we have to do more to address their concerns. In this symposium, the panel will discuss how even with a legacy of stigma and discrimination, patients can become empowered to seek the care they deserve. The expert faculty will share examples of how treatment individualisation and integration of HCV care with multiple stakeholders has helped to overcome these barriers and is improving rates of treatment uptake in these patients.
Concurrent Session 2
2:25 PM - 3:55 PM 		Hepatitis C Models of Care Abstracts
3:55 PM - 4:25 PM
Coffee Break & Exhibition Open - Wednesday Afternoon
Concurrent Session 3
4:25 PM - 5:20 PM 		Research Oral Abstract Session - Changes in Drug Use
5:20 PM - 5:50 PM
Virtual Networking - Day 1

Thursday, October 14, 2021

Track 1
Track 2
7:30 AM - 7:59 AM
Portal Demonstration Video - Day 2
8:00 AM - 8:45 AM Industry Sponsored Symposium - Experience and Impact of different models of care using point-of-care testing for Hepatitis C
8:55 AM - 10:30 AM Plenary Session - Thursday
10:30 AM - 11:10 AM
Coffee Break & Exhibition Open - Thursday Morning
Concurrent Session 4
11:10 AM - 12:45 PM 		Progress Towards Hepatitis C Elimination Providing Care in the Context of Systemic Public Health Issues
12:45 PM - 2:25 PM
Lunch & Exhibition Open - Thursday
1:15 PM - 2:15 PM Industry Sponsored Symposium: Prioritizing decentralized care for HCV-infected patients: A unique opportunity for addiction medicine
Please join Prof. Brian Conway, Jody Gilmore, MSN, ANP-BC, and Prof. Andrew Lloyd at 1:15 PM (AEDT) / 4:15 AM (CEST) on 14th October 2021 for an engaging AbbVie-sponsored virtual symposium. The session will explore the rationale for prioritizing HCV care for people who inject drugs (PWID), highlight the benefits of cure for the individual patient, and discuss the importance of simplified and decentralized care and how it can be adapted to a variety of settings to reach marginalized patient groups.
Concurrent Session 5
2:25 PM - 3:35 PM 		Research Oral Abstract Session - Progress Towards Hepatitis C Elimination Research Oral Abstract Session - Providing Care in the Context of Systemic Public Health Issues
3:35 PM - 4:10 PM
Coffee Break & Exhibition Open - Thursday Afternoon
Concurrent Session 6
4:10 PM - 5:25 PM 		Research Oral Abstract Session - HCV Care in Prisons Models of Care Abstracts - Thursday
5:25 PM - 5:55 PM
Virtual Networking - Day 2
8:00 PM - 9:00 PM Early-Mid Career Researcher Session: Public Engagement and Communications Workshop
Track 1
Track 2
7:30 AM - 7:59 AM
Portal Demonstration Video - Day 2
8:00 AM - 8:45 AM Industry Sponsored Symposium - Experience and Impact of different models of care using point-of-care testing for Hepatitis C
8:55 AM - 10:30 AM Plenary Session - Thursday
10:30 AM - 11:10 AM
Coffee Break & Exhibition Open - Thursday Morning
Concurrent Session 4
11:10 AM - 12:45 PM 		Progress Towards Hepatitis C Elimination Providing Care in the Context of Systemic Public Health Issues
12:45 PM - 2:25 PM
Lunch & Exhibition Open - Thursday
1:15 PM - 2:15 PM Industry Sponsored Symposium: Prioritizing decentralized care for HCV-infected patients: A unique opportunity for addiction medicine
Please join Prof. Brian Conway, Jody Gilmore, MSN, ANP-BC, and Prof. Andrew Lloyd at 1:15 PM (AEDT) / 4:15 AM (CEST) on 14th October 2021 for an engaging AbbVie-sponsored virtual symposium. The session will explore the rationale for prioritizing HCV care for people who inject drugs (PWID), highlight the benefits of cure for the individual patient, and discuss the importance of simplified and decentralized care and how it can be adapted to a variety of settings to reach marginalized patient groups.
Concurrent Session 5
2:25 PM - 3:35 PM 		Research Oral Abstract Session - Progress Towards Hepatitis C Elimination Research Oral Abstract Session - Providing Care in the Context of Systemic Public Health Issues
3:35 PM - 4:10 PM
Coffee Break & Exhibition Open - Thursday Afternoon
Concurrent Session 6
4:10 PM - 5:25 PM 		Research Oral Abstract Session - HCV Care in Prisons Models of Care Abstracts - Thursday
5:25 PM - 5:55 PM
Virtual Networking - Day 2
8:00 PM - 9:00 PM Early-Mid Career Researcher Session: Public Engagement and Communications Workshop

Track 1
7:30 AM - 7:59 AM
Portal Demonstration Video - Day 2
8:00 AM - 8:45 AM Industry Sponsored Symposium - Experience and Impact of different models of care using point-of-care testing for Hepatitis C
8:55 AM - 10:30 AM Plenary Session - Thursday
10:30 AM - 11:10 AM
Coffee Break & Exhibition Open - Thursday Morning
Concurrent Session 4
11:10 AM - 12:45 PM 		Progress Towards Hepatitis C Elimination
12:45 PM - 2:25 PM
Lunch & Exhibition Open - Thursday
1:15 PM - 2:15 PM Industry Sponsored Symposium: Prioritizing decentralized care for HCV-infected patients: A unique opportunity for addiction medicine
Please join Prof. Brian Conway, Jody Gilmore, MSN, ANP-BC, and Prof. Andrew Lloyd at 1:15 PM (AEDT) / 4:15 AM (CEST) on 14th October 2021 for an engaging AbbVie-sponsored virtual symposium. The session will explore the rationale for prioritizing HCV care for people who inject drugs (PWID), highlight the benefits of cure for the individual patient, and discuss the importance of simplified and decentralized care and how it can be adapted to a variety of settings to reach marginalized patient groups.
Concurrent Session 5
2:25 PM - 3:35 PM 		Research Oral Abstract Session - Progress Towards Hepatitis C Elimination
3:35 PM - 4:10 PM
Coffee Break & Exhibition Open - Thursday Afternoon
Concurrent Session 6
4:10 PM - 5:25 PM 		Research Oral Abstract Session - HCV Care in Prisons
5:25 PM - 5:55 PM
Virtual Networking - Day 2
8:00 PM - 9:00 PM Early-Mid Career Researcher Session: Public Engagement and Communications Workshop

Track 2
7:30 AM - 7:59 AM
Portal Demonstration Video - Day 2
8:00 AM - 8:45 AM Industry Sponsored Symposium - Experience and Impact of different models of care using point-of-care testing for Hepatitis C
8:55 AM - 10:30 AM Plenary Session - Thursday
10:30 AM - 11:10 AM
Coffee Break & Exhibition Open - Thursday Morning
Concurrent Session 4
11:10 AM - 12:45 PM 		Providing Care in the Context of Systemic Public Health Issues
12:45 PM - 2:25 PM
Lunch & Exhibition Open - Thursday
1:15 PM - 2:15 PM Industry Sponsored Symposium: Prioritizing decentralized care for HCV-infected patients: A unique opportunity for addiction medicine
Please join Prof. Brian Conway, Jody Gilmore, MSN, ANP-BC, and Prof. Andrew Lloyd at 1:15 PM (AEDT) / 4:15 AM (CEST) on 14th October 2021 for an engaging AbbVie-sponsored virtual symposium. The session will explore the rationale for prioritizing HCV care for people who inject drugs (PWID), highlight the benefits of cure for the individual patient, and discuss the importance of simplified and decentralized care and how it can be adapted to a variety of settings to reach marginalized patient groups.
Concurrent Session 5
2:25 PM - 3:35 PM 		Research Oral Abstract Session - Providing Care in the Context of Systemic Public Health Issues
3:35 PM - 4:10 PM
Coffee Break & Exhibition Open - Thursday Afternoon
Concurrent Session 6
4:10 PM - 5:25 PM 		Models of Care Abstracts - Thursday
5:25 PM - 5:55 PM
Virtual Networking - Day 2
8:00 PM - 9:00 PM Early-Mid Career Researcher Session: Public Engagement and Communications Workshop

Friday, October 15, 2021

Track 1
Track 2
Track 3
7:00 AM - 8:00 AM
INHSU Prison Session
7:00 AM - 12:30 PM
Speaker Tech Support
8:30 AM - 8:54 AM
Portal Demonstration Video - Day 3
8:55 AM - 10:30 AM Plenary Session - Friday
10:30 AM - 10:55 AM
Coffee Break & Exhibition Open - Friday Morning
Concurrent Session 7
10:55 AM - 12:30 PM 		Research Oral Abstract Session - Innovations in Hepatitis C Testing and Treatment Models of Care Abstracts - Friday Early-Mid Career Researcher Session: Career Pathways beyond Academia
12:30 PM - 2:00 PM
Lunch & Exhibition Open - Friday
2:00 PM - 3:50 PM Awards and Closing Session
Track 1
Track 2
7:00 AM - 8:00 AM
INHSU Prison Session
7:00 AM - 12:30 PM
Speaker Tech Support
8:30 AM - 8:54 AM
Portal Demonstration Video - Day 3
8:55 AM - 10:30 AM Plenary Session - Friday
10:30 AM - 10:55 AM
Coffee Break & Exhibition Open - Friday Morning
Concurrent Session 7
10:55 AM - 12:30 PM 		Research Oral Abstract Session - Innovations in Hepatitis C Testing and Treatment Models of Care Abstracts - Friday
12:30 PM - 2:00 PM
Lunch & Exhibition Open - Friday
2:00 PM - 3:50 PM Awards and Closing Session

Track 3
7:00 AM - 8:00 AM
INHSU Prison Session
7:00 AM - 12:30 PM
Speaker Tech Support
8:30 AM - 8:54 AM
Portal Demonstration Video - Day 3
8:55 AM - 10:30 AM Plenary Session - Friday
10:30 AM - 10:55 AM
Coffee Break & Exhibition Open - Friday Morning
Concurrent Session 7
10:55 AM - 12:30 PM 		Early-Mid Career Researcher Session: Career Pathways beyond Academia
12:30 PM - 2:00 PM
Lunch & Exhibition Open - Friday
2:00 PM - 3:50 PM Awards and Closing Session

Track 1
7:00 AM - 8:00 AM
INHSU Prison Session
7:00 AM - 12:30 PM
Speaker Tech Support
8:30 AM - 8:54 AM
Portal Demonstration Video - Day 3
8:55 AM - 10:30 AM Plenary Session - Friday
10:30 AM - 10:55 AM
Coffee Break & Exhibition Open - Friday Morning
Concurrent Session 7
10:55 AM - 12:30 PM 		Research Oral Abstract Session - Innovations in Hepatitis C Testing and Treatment
12:30 PM - 2:00 PM
Lunch & Exhibition Open - Friday
2:00 PM - 3:50 PM Awards and Closing Session

Track 2
7:00 AM - 8:00 AM
INHSU Prison Session
7:00 AM - 12:30 PM
Speaker Tech Support
8:30 AM - 8:54 AM
Portal Demonstration Video - Day 3
8:55 AM - 10:30 AM Plenary Session - Friday
10:30 AM - 10:55 AM
Coffee Break & Exhibition Open - Friday Morning
Concurrent Session 7
10:55 AM - 12:30 PM 		Models of Care Abstracts - Friday
12:30 PM - 2:00 PM
Lunch & Exhibition Open - Friday
2:00 PM - 3:50 PM Awards and Closing Session

Track 3
7:00 AM - 8:00 AM
INHSU Prison Session
7:00 AM - 12:30 PM
Speaker Tech Support
8:30 AM - 8:54 AM
Portal Demonstration Video - Day 3
8:55 AM - 10:30 AM Plenary Session - Friday
10:30 AM - 10:55 AM
Coffee Break & Exhibition Open - Friday Morning
Concurrent Session 7
10:55 AM - 12:30 PM 		Early-Mid Career Researcher Session: Career Pathways beyond Academia
12:30 PM - 2:00 PM
Lunch & Exhibition Open - Friday
2:00 PM - 3:50 PM Awards and Closing Session

Tuesday, October 19, 2021

Track 1
6:00 AM - 6:30 AM
REHEARSAL: Innovations in HCV Diagnostics: Real-World Implementation
8:00 PM - 9:15 PM Hepatitis C self-testing: empowering people who inject drugs and increasing access to HCV testing and care
Track 1
6:00 AM - 6:30 AM
REHEARSAL: Innovations in HCV Diagnostics: Real-World Implementation
8:00 PM - 9:15 PM Hepatitis C self-testing: empowering people who inject drugs and increasing access to HCV testing and care

Track 1
6:00 AM - 6:30 AM
REHEARSAL: Innovations in HCV Diagnostics: Real-World Implementation
8:00 PM - 9:15 PM Hepatitis C self-testing: empowering people who inject drugs and increasing access to HCV testing and care

Thursday, October 21, 2021

Track 1
11:30 AM - 12:00 PM
REHEARSAL: Tanya Applegate
Track 1
11:30 AM - 12:00 PM
REHEARSAL: Tanya Applegate

Track 1
11:30 AM - 12:00 PM
REHEARSAL: Tanya Applegate

Friday, October 22, 2021

Track 1
6:00 AM - 7:30 AM Innovations in HCV Diagnostics: Real-World Implementation
Track 1
6:00 AM - 7:30 AM Innovations in HCV Diagnostics: Real-World Implementation

Track 1
6:00 AM - 7:30 AM Innovations in HCV Diagnostics: Real-World Implementation

Monday, October 25, 2021

Track 1
7:30 PM - 9:00 PM
Speaker Rehearsal: HCV Testing in Community by the Community
Track 1
7:30 PM - 9:00 PM
Speaker Rehearsal: HCV Testing in Community by the Community

Track 1
7:30 PM - 9:00 PM
Speaker Rehearsal: HCV Testing in Community by the Community

Tuesday, October 26, 2021

Track 1
8:00 PM - 9:00 PM Addressing the Critical Role of Communities in Research
Track 1
8:00 PM - 9:00 PM Addressing the Critical Role of Communities in Research

Track 1
8:00 PM - 9:00 PM Addressing the Critical Role of Communities in Research

Wednesday, October 27, 2021

Track 1
6:00 AM - 6:45 AM
Rehearsal: Crackdown Podcast Listen Party and Panel Discussion
Track 1
6:00 AM - 6:45 AM
Rehearsal: Crackdown Podcast Listen Party and Panel Discussion

Track 1
6:00 AM - 6:45 AM
Rehearsal: Crackdown Podcast Listen Party and Panel Discussion

Thursday, October 28, 2021

Track 1
8:00 PM - 9:00 PM Workshop: HCV Testing in Community by the Community
Track 1
8:00 PM - 9:00 PM Workshop: HCV Testing in Community by the Community

Track 1
8:00 PM - 9:00 PM Workshop: HCV Testing in Community by the Community

Friday, October 29, 2021

Track 1
8:00 AM - 8:30 AM
Rehearsal: Caitlin Shane
Track 1
8:00 AM - 8:30 AM
Rehearsal: Caitlin Shane

Track 1
8:00 AM - 8:30 AM
Rehearsal: Caitlin Shane

Tuesday, November 2, 2021

Track 1
6:00 PM - 6:45 PM
Rehearsal: Decriminalisation of Drug Use
Track 1
6:00 PM - 6:45 PM
Rehearsal: Decriminalisation of Drug Use

Track 1
6:00 PM - 6:45 PM
Rehearsal: Decriminalisation of Drug Use

Wednesday, November 3, 2021

Track 1
6:00 AM - 7:30 AM Crackdown Podcast Listen Party and Panel Discussion
7:00 PM - 7:30 PM
Rehearsal: Hon. Fortune Daniel Molokela-Tsiye
Track 1
6:00 AM - 7:30 AM Crackdown Podcast Listen Party and Panel Discussion
7:00 PM - 7:30 PM
Rehearsal: Hon. Fortune Daniel Molokela-Tsiye

Track 1
6:00 AM - 7:30 AM Crackdown Podcast Listen Party and Panel Discussion
7:00 PM - 7:30 PM
Rehearsal: Hon. Fortune Daniel Molokela-Tsiye

Friday, November 5, 2021

Track 1
6:00 AM - 7:30 AM Decriminalisation of drug use: an interactive workshop to discuss design considerations
Track 1
6:00 AM - 7:30 AM Decriminalisation of drug use: an interactive workshop to discuss design considerations

Track 1
6:00 AM - 7:30 AM Decriminalisation of drug use: an interactive workshop to discuss design considerations

Footer image
loading